Frazier Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.2K Sell
122
-45
-27% -$15.4K 0.02% 200
2026
Q1
$58.8K Buy
167
+90
+117% +$32.1K 0.03% 170
2025
Q4
$25.2K Sell
77
-340
-82% -$108K 0.01% 245
2025
Q3
$118K Sell
417
-96
-19% -$27.8K 0.07% 86
2025
Q2
$143K Buy
513
+158
+45% +$44.8K 0.1% 78
2025
Q1
$111K Buy
355
+43
+14% +$12.7K 0.09% 80
2024
Q4
$80.9K Buy
312
+6
+2% +$1.78K 0.06% 97
2024
Q3
$98.6K Buy
306
+296
+2,960% +$96.8K 0.08% 94
2024
Q2
$3.13K Sell
10
-6
-38% -$1.76K ﹤0.01% 728
2024
Q1
$4.55K Buy
+16
New +$4.68K ﹤0.01% 619

Other funds holding AMGN

Frazier Financial Advisors's AMGN Position: Q2 2026 in Review

Frazier Financial Advisors reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $15.4K and leaving 122 shares worth $44.2K. The position accounts for 0.02% of the portfolio, ranked #200.

Frazier Financial Advisors first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $143K in Q2 2025. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Frazier Financial Advisors held 122 shares of Amgen worth $44.2K as of Q2 2026.
  • Frazier Financial Advisors sold 45 Amgen shares in Q2 2026, an estimated $15.4K.
  • Amgen made up 0.02% of Frazier Financial Advisors's portfolio in Q2 2026, its #200 holding.
  • Frazier Financial Advisors first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Frazier Financial Advisors's Amgen position peaked at $143K in Q2 2025.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.